Italy In-Vitro Diagnostics Market
With a CAGR of 6.68% from 2024 to 2032, the Italy In-Vitro Diagnostics Market, which was valued at US$ 2.61 billion in 2023, is expected to increase to US$ 4.67 billion by 2032. Italy In-Vitro Diagnostics Market The country’s rising frequency of chronic diseases and the large sums of money that industry leaders have been investing in research and development to develop state-of-the-art technology for examining fresh ways to illness detection are expected to fuel growth as well.
Test Types – Market breakup in 11 viewpoints:
- ELISA & CLIA
- PCR
- Rapid Test
- Fluorescence Immunoassays (FIA)
- In Situ Hybridization
- Transcription Mediated Amplification
- Sequencing
- Colorimetric Immunoassay
- Radioimmunoassay (RIA)
- Isothermal Nucleic Acid Amplification Technology
- Others
Italy In-Vitro Diagnostics Industry Overview
Italy is predicted to see a rise in the prevalence of a number of diseases, including cancer, autoimmune disorders, myocardial infarctions, arrhythmias, and inflammatory ailments, which will drive up demand for IVD testing. For instance, approximately 174,759 new cancer cases were registered in Italy in 2020, according to Globocan. Among the most common malignancies detected in Italy are bladder, lung, colorectal, prostate, and breast cancers. Similarly, the country’s adult population had about 4.4 million cases of diabetes in 2022, according to the International Diabetes Federation. Obesity, a sedentary lifestyle, unhealthy eating habits, and high alcohol and cigarette usage are likely to increase the prevalence of target diseases in the nation.
In the upcoming years, the expansion of the IVD market is anticipated to be fueled by changes in regulatory laws. For example, the Italian government updated its national regulatory framework pertaining to IVD products in the nation in September 2022. It is anticipated that the new regulations will guarantee a greater degree of IVD product safety throughout the nation. Additionally, the governments of France and Italy partnered in September 2021 to distribute the LoopDeeLab device—which is based on RT Lamp molecular biology techniques—in Italy. In 45 minutes, this instrument can identify COVID-19 infection. Throughout the projected period, the Italy in vitro diagnostics market is expected to rise strongly due to these novel breakthroughs.
Products – Market breakup in 3 viewpoints:
- Services
- Instruments
- Reagents
Technology – Market breakup in 7 viewpoints:
- Immunoassay
- Clinical Chemistry
- Molecular Diagnostics/Genetics
- Hematology
- Microbiology
- Coagulation
- Others
Growth drivers of Italy In-vitro Diagnostics Market
Rising Aging Population
The need for in vitro diagnostics is greatly impacted by Italy’s aging population since chronic diseases are more common in the elderly. In order to successfully manage health issues in light of this demographic shift, improved diagnostic testing is required, which will eventually propel growth in the IVD market and improve patient outcomes throughout the healthcare system.
Application – Market breakup in 8 viewpoints:
- Infectious Disease
- Diabetes
- Cardiology
- Oncology
- Nephrology
- Autoimmune Diseases
- Drug Testing
- Other Applications
End User – Market breakup in 4 viewpoints:
- Hospitals
- Laboratories
- Home – Care
- Others
Italy In-vitro Diagnostics Market Trends
Instrument Segment is Anticipated to Have a Significant Share in the Market
Instruments are essential to the quick and precise diagnosis of illnesses in in vitro diagnostics as well as the execution of numerous assays. These tools can be used for a variety of activities, including preparation of samples, analysis, and result interpretation. They are available in various varieties, such as mass spectrometers, chromatography systems, spectrophotometers, and analyzers. Furthermore, the instruments are in high demand because they are among the most necessary parts of any diagnostic facility or clinic.
The government and corporate sectors are investing more in primary and community care, reorganizing healthcare facilities, and installing cutting-edge medical equipment. This is fostering the expansion of the market and raising the need for in-vitro diagnostic equipment in Italian healthcare settings. For instance, 380 new community hospitals and 1,350 new community health houses are to be established as part of Italy’s National Recovery and Resilience Plan, according to a December 2021 article published by the European Parliament. In addition, the plan calls for the purchase of 3,133 pieces of cutting-edge technology and the structural renovation of hospitals. Thus, during the course of the forecast period, the establishment of new centers and the expansion of current ones are anticipated to propel the need for in-vitro diagnostic instruments in Italy.
Related Report:
Europe Next Generation Sequencing Market
Anxiety Disorders and Depression Treatment Market
All the Key players have been covered from 5 Viewpoints:
- Overviews
- Key Person
- Recent Developments & Strategies
- Product Portfolio & Product Launch in Last 1 Year
- Revenue
Company Analysis:
- Roche Diagnostics
- Abbott Diagnostics
- Siemens Healthineers
- Danaher Corporation
- Thermo Fisher Scientific
- Sysmex Corporation
About the Company:
Renub Research is a Market Research and Consulting Company. We have more than 14 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food Beverages, Power Energy, Information Technology, Telecom Internet, Chemical, Logistics Automotive, Consumer Goods Retail, Building, and Construction, Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more.
Contact Us:
Renub Research
Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)
Email: info@renub.com
LinkedIn: https://in.linkedin.com/company/renub-research
Web: www.renub.com
Thank You
